Ground Zero Pharmaceuticals Announces Milestones in Pharmaceutical and Biotechnology Outsourcing Services.

PR Newswire Europe, November, 2005

IRVINE, California, November 8 /PRNewswire/ -- The climate for pharmaceutical and biotechnology products has changed with increased emphasis on integrated product development, FDA reorganization, and recognition of the need for early markers of safety. Combination products are a major growth area. Strategic global planning and cost-effective development programs can lead to timely FDA approvals. The key is an honest, thorough recognition of early indications of safety issues and efficacy and the proper application of regulatory knowledge to the process. This can reduce unnecessary expenditures of time, funding and scarce resources, particularly for small firms. The accelerated movement toward electronic marketing submissions will aid the regulatory authorities in...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here